COVID-19ワクチン接種,全因死亡率,がんによる入院:イタリアの州における30ヶ月のコホート研究
Cecilia Acuti Martellucci1, Angelo Capodici1, Graziella Soldato2
1Department of Medical and Surgical Sciences, University of Bologna, 40100 Bologna, Italy.
EXCLI journal
|August 29, 2025
まとめ
COVID-19ワクチン接種は,全原因による死亡リスクの低下と関連していました. しかし,癌の入院リスクがわずかに増加することが観察されました,特に以前の感染のない人では,この発見はさらなる調査を必要とします.
科学分野:
- 流行病学について
- 公衆衛生
- 腫瘍学
背景:
- 逸話的な報告では,SARS-CoV-2ワクチン接種とがんとの関連が示唆された.
- この関連性を評価した正式な研究はありませんでした.
- この研究は,がんのリスクに対するワクチンの影響に関する堅実なデータの必要性に対応しています.
研究 の 目的:
- SARS-CoV-2 免疫状態に基づいて,全因死亡および癌入院のリスクを評価する.
- 集団全体のデータを分析し,潜在的な関連性を理解する.
主な方法:
- 2021年6月から2023年12月までのペスカラ州全人口のコホート分析.
- 主要な人口と健康要因に調整されたコックスモデルを用いて,国立保健システムデータを活用した.
- ワクチン接種と未接種者の比較結果 (≥1回,≥3回)
主要な成果:
- ワクチン接種を受けた人 (≥1回) は,未接種者と比較して,あらゆる原因で死亡するリスクが著しく低かった.
- ワクチンを接種した個体では,癌の入院リスクがわずかに高かった (HR: 1.23; 95% CI: 1. 11 - 1.37).
- このがんの入院関連は,以前のSARS-CoV-2感染のない人だけに有意であり,12ヶ月の遅れで逆転した.
結論:
- SARS-CoV-2ワクチン接種は,あらゆる原因による死亡率の大幅な減少と関連しています.
- ワクチン接種に関連した癌入院リスクは,感染状態,癌部位,および遅延時間によって異なります.
- 発見は,潜在的なバイアス (例えば,健康なワクチンバイアス) と測定されていない混同因子によるものです.
関連する概念動画
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
Bias in Epidemiological Studies
671
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
671
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
Rous Sarcoma Virus (RSV) and Cancer
5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.4K
Prevalence and Incidence
790
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
790


